Rising input costs, export slump take a toll on drug companies' health
Published on: May 19, 2026, 1:57 a.m. | Source: The Economic Times
India's drug makers are facing a double blow. A weaker rupee makes imported raw materials more expensive. Global economic worries are also slowing down demand for Indian medicines abroad. This is squeezing profits for manufacturers. Companies are trying to focus on more profitable products. The situation presents a tough operating environment for the industry.
